Staphylococcus aureus references

Journal papers, reports and conference posters

• 2009
• 2008
• 2007
• 2006
• 2005
• 2004
• 2003
• 2002
• 2001 and earlier

HPA CDR-Weekly publications are listed under the Voluntary surveillance and Mandatory surveillance  sections of the website.

Guidelines can be found under the Guidelines and Department of Health letters sections of the website.

2009

• Pearson et al. Mandatory meticillin resistant Staphylococcus aureus (MRSA) bacteraemia surveillance in England: A small area estimation method to model reduction in MRSA bacteraemia (PDF, 661 KB) Society for Healthcare Epidemiology of America International conference 2009: poster presentation
• Pearson et al. Mandatory meticillin resistant Staphylococcus aureus (MRSA) bacteraemia surveillance in England: Lessons to sustain improvement learned from differential reductions achieved in males and females (PDF, 818 KB) Society for Healthcare Epidemiology of America International conference 2009: poster presentation
• Pearson et al. Impact of mandatory surveillance on the measurement of meticillin-resistant Staphylococcus aureus bacteraemia in the English NHS: comparison of mandatory and voluntary surveillance reporting systems (PDF, 673 KB) European Congress for Microbiology and Infectious Diseases conference 2009: poster presentation 

2008

• Pearson et al. Presumptive sources of Meticillin resistant Staphylococcus aureus (MRSA) bacteraemia: Results from enhanced surveillance in English National Health Service (NHS) acute Trusts (PDF, 2.9 MB) Federation of Infections Societies scientific conference 2008 : poster presentation
• Bridger et al. Identification of hospital and community onset of Meticillin-resistant Staphylococcus aureus (MRSA) Bacteraemia: Results of enhanced surveillance in NHS acute Trusts (PDF, 3.7 MB) Health Protection conference 2008 : poster presentation

2007

• Ellington M J, et al. Is Panton-Valentine leucocidin associated with the pathogenesis of Staphylococcus aureus bacteraemia in the UK? J Antimicrob Chemother 2007; 60 (2):402-5
• November 2007National Confidential Study of Deaths Following Meticillin-Resistant (MRSA) Infection. (PDF, 1.2 MB)
  
  .
• November 2007 Health Protection Agency.  Surveillance of Healthcare Associated Infections Report 2007 .

2006

• Pearson et al. Preliminary results from the national mandatory MRSA bacteraemia enhanced surveillance scheme in England: October 2005 - March 2006 (PDF, 746 KB) Hospital Infection Society International conference 2006 : poster presentation
• Pearson et al. Mandatory enhanced surveillance of MRSA bacteraemia in English hospitals: distribution and significance of admission diagnosed cases of MRSA bacteraemia. (PDF, 520 KB)
  
  Interscience Conference on Antimicrobial Agents and Chemotherapy; 2006 September 26-30; San Francisco, USA
• Health Protection Agency. Surveillance of Surgical Site Infection in England: October 1997 September 2005 (PDF, 1.4 MB)
  
  . June 2006
• North S E, et al. Correlation Between MIC and Number of Mutated 23S rRNA Genes in Oxazolidinone-Resistant (PDF, 467 KB)
  
  . 16th European Congress of Clinical Microbiology and Infectious Diseases 2006 April 1- 4 Nice .

2005

• Hill R L R, et al. "Linezolid- Resistant ST36 MRSA from Two Paediatric Cystic Fibrosis Patients, Following Prolonged Treatment." (PDF, 538 KB)
  
  The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy 2005 December 16-19, Washington DC
• Mushtaq S, et al. In-Vitro Activity of Cephalosporin PP1-0903M vs. Critical Resistance Types. (PDF, 103 KB)
  
  The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy 2005 December 16-19, Washington DC
• North S E, et al. Chloramphenicol-Selected Mutants of May Show Cross-Resistance to Linezolid. (PDF, 586 KB)
  
  The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy 2005 December 16-19, Washington DC
• North S E, et al. Selection of Linezolid Resistance in Hypermutable and Wild-Type (PDF, 108 KB)
  
  Selection of Linezolid Resistance in Hypermutable and Wild-Type (PDF, 108 KB)
  
  . 15th European Congress of Clinical Microbiology and Infectious Diseases 2005 April 2-5 Copenhagen.
• North S E, et al. Effect Of Erythromycin On The Selection Of Linezolid Resistance In Hypermutable And Clinical Isolates Of (PDF, 71 KB)
  
  5th European Congress of Clinical Microbiology and Infectious Diseases 2005 April 2-5 Copenhagen . 
• North S E, et al. Novel Pyrosequencing Assays to Detect T2500A and Other Mutations Conferring Linezolid Resistance in (PDF, 533 KB)
  
  . The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy 2005 December 16-19, Washington DC.
• Warner M, et al. In-vitro Activity of Oxazolidinone RWJ-416457 Linezolid-Resistant and -Susceptible Staphylococci and Enterococci. (PDF, 121 KB)
  
  The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy 2005 December 16-19, Washington DC 

2004

• Griffiths C, et al. Trends in MRSA in England and Wales: analysis of morbidity and mortality data for 1993-2002. Health Stat.Q. 2004; 21:15-22
• Khairulddin N, et al. Emergence of methicillin resistant Staphylococcus aureus (MRSA) bacteraemia among children in England and Wales, 1990-2001. Arch Dis Child 2004;89(4):378-379
• Mushtaq S, et al. "In-vitro Anti-staphylococcal and Anti-streptococcal Activity of Dalbavancin, Assessed by British and NCCLS Methods." (PDF, 275 KB)
  
  14th European Congress of Clinical Microbiology and Infectious Diseases 2004 May 1-4, Prague

2003

• Al-Doori z, et al. Identifying The SCCmec Types of MRSA - A Comparison of Three Primer Sets (PDF, 220 KB)
  
  . 13th European Congress of Clinical Microbiology and Infectious Diseases 2003 May 10-13, Glasgow .
• Johnson A P, et al. Activity of Daptomycin (DAP) Against Multi-resistant Gram-positive Bacteria. Including Enterococci and Resistant to Linezolid. (PDF, 47 KB)
  
  The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy 2003 September 14-17 Chicago .
• Johnson A P, et al. Calcium-supplemented E-test Strips for Susceptibility Testing with Daptomycin (DAP) (PDF, 48 KB)
  
  . The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy 2003 September 14-17 Chicago 

2002

• Duckworth G, et al. Surveillance for S. aureus bacteraemias is compulsory. BMJ 2002;324:240-1
• Griffiths C, et al. Trends in MRSA in England and Wales: analysis of morbidity and mortality data for 1993-2002. Health Stat Q 2004;21:15-22
• Woodford N, et al. Enterococcal and staphylococcal resistance to the new oxazolidinone AZD2563 is difficult to select . (PDF, 52 KB)
  
  The 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy 2002 September 27-30 San Diego

2001 and earlier

• Livermore DM. Antibiotic resistance in staphylococci. Int J Antimicrob Agents 2000;16 Suppl 1:S3-10
• Reacher MH, et al. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. BMJ 2000;320:213-6

Last reviewed: 23 December 2011